| Literature DB >> 20439954 |
Joanna R M Armstrong Schellenberg1, Kizito Shirima, Werner Maokola, Fatuma Manzi, Mwifadhi Mrisho, Adiel Mushi, Hassan Mshinda, Pedro Alonso, Marcel Tanner, David M Schellenberg.
Abstract
Intermittent preventive treatment of malaria in infants (IPTi) with sulphadoxine-pyrimethamine shows evidence of efficacy in individually randomized, controlled trials. In a large-scale effectiveness study, IPTi was introduced in April 2005 by existing health staff through routine contacts in 12 randomly selected divisions out of 24 in 6 districts of rural southern Tanzania. Coverage and effects on malaria and anemia were estimated through a representative survey in 2006 with 600 children aged 2-11 months. Coverage of IPTi was 47-76% depending on the definition. Using an intention to treat analysis, parasitemia prevalence was 31% in intervention and 38% in comparison areas (P = 0.06). In a "per protocol" analysis of children who had recently received IPTi, parasite prevalence was 22%, 19 percentage points lower than comparison children (P = 0.01). IPTi can be implemented on a large scale by existing health service staff, with a measurable population effect on malaria, within 1 year of launch.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20439954 PMCID: PMC2861388 DOI: 10.4269/ajtmh.2010.09-0207
Source DB: PubMed Journal: Am J Trop Med Hyg ISSN: 0002-9637 Impact factor: 2.345